Lymphocyte depleted Hodgkin lymphoma is a rare subtype of Hodgkin lymphoma characterized by a predominance of Reed-Sternberg cells and a depletion of lymphocytes. This condition is clinically significant as it often presents with advanced disease and requires aggressive treatment. The ICD-10 Code C81.3A facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage patient outcomes.
ICD-10 Code C81.3A represents Lymphocyte depleted Hodgkin lymphoma, in remission, indicating that the patient has undergone treatment and shows no active disease. This code is used when documenting the patient's clinical status post-treatment, ensuring accurate billing and continuity of care. It is essential for healthcare providers to utilize this code to reflect the patient's remission status accurately.
Lymphocyte depleted Hodgkin lymphoma is a variant of Hodgkin lymphoma characterized by a significant reduction in lymphocytes and a predominance of Reed-Sternberg cells. This subtype is often associated with advanced disease at diagnosis and requires prompt medical intervention. The condition necessitates careful monitoring and treatment to achieve remission.
ICD-10 Code C81.3A is utilized in SOAP notes to document the patient's remission status following treatment for Lymphocyte depleted Hodgkin lymphoma. This code plays a crucial role in capturing the patient's clinical history, treatment response, and ongoing management in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C81.3A connects subjective patient reports and objective clinical findings to a formal diagnosis of Lymphocyte depleted Hodgkin lymphoma in remission. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of Lymphocyte depleted Hodgkin lymphoma in remission involves ongoing monitoring and supportive care to prevent relapse. Hospitalization may be necessary for severe cases or complications.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C81.3A is critical in medical billing, particularly in hospital and outpatient settings, to ensure accurate claims for patients in remission.
| CPT Code | Description |
|---|---|
| 99214 | Established patient office visit, moderate complexity. |
| 36415 | Collection of venous blood by venipuncture. |
| 85025 | Complete blood count with automated differential. |
Common Questions About Using ICD-10 Code C81.3A for Lymphocyte depleted Hodgkin lymphoma, in remission
What does it mean for a patient to be in remission?
Being in remission means that the signs and symptoms of Lymphocyte depleted Hodgkin lymphoma have significantly decreased or disappeared following treatment. This status is crucial for determining ongoing care and monitoring.
How often should follow-up appointments occur for patients in remission?
Patients in remission typically require follow-up appointments every 3 to 6 months to monitor for any signs of relapse and to manage any long-term effects of treatment.
What are the common treatments for Lymphocyte depleted Hodgkin lymphoma?
Common treatments include chemotherapy, radiation therapy, and in some cases, stem cell transplantation. The treatment plan is tailored to the individual based on disease stage and patient health.
Is Lymphocyte depleted Hodgkin lymphoma contagious?
No, Lymphocyte depleted Hodgkin lymphoma is not contagious. It is a type of cancer that arises from the lymphatic system and cannot be transmitted from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes